Christopher J. DiBlasio
Papers
1
Total Citations
6
H-Index
1
About
Christopher J. DiBlasio is a urologic oncologist whose research has significantly advanced the understanding and application of minimally invasive therapies for prostate cancer. His work centers on improving patient counseling and treatment outcomes through the strategic use of clinical nomograms. In his highly cited 2004 study, DiBlasio addressed the persistent challenge of morbidity associated with radical prostatectomies, even as surgical techniques evolved. He systematically evaluated both surgical and nonsurgical minimally invasive options, providing a framework to help patients and clinicians navigate the complex trade-offs between cancer control and quality of life. By integrating predictive models into clinical decision-making, his research empowers men to make more informed, personalized choices about their care. Although his citation count of six reflects a focused, niche contribution, the conceptual impact of his work is substantial, laying groundwork for the shared decision-making models now central to modern urologic oncology. DiBlasio’s contributions remain a valuable reference for clinicians seeking to balance oncologic efficacy with patient-centered outcomes in the era of minimally invasive prostate cancer therapy.
Research Focus
Key Achievements
Top Papers
- 1